Allergan Inc
AGN
AGN was delisted on the 16th of March, 2015.
5 hedge funds and large institutions have $182M invested in Allergan Inc in 2015 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 801 closing their positions.
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
99% less funds holding
Funds holding: 819 → 5 (-814)
100% less capital invested
Capital invested by funds: $63B → $182M (-$62.9B)
100% less funds holding in top 10
Funds holding in top 10: 104 → 0 (-104)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 801
Top Buyers
| 1 |
ECM
Everence Capital Management
Goshen,
Indiana
|
+$202K |
Top Sellers
AGN Hedge Fund Activity: Q1 2015 in Review
5 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Allergan Inc (AGN) for Q1 2015, worth a combined $182M — down 100% from $63B a quarter earlier.
Sellers outnumbered buyers: 801 funds closed out of AGN and 0 opened new positions — a net loss of 801 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was Everence Capital Management, adding an estimated $202K. The largest seller was Pershing Square Capital Management, exiting entirely with an estimated $5.66B sold.
- 5 institutional investors held Allergan Inc (AGN) as of Q1 2015, down from 819 in Q4 2014.
- Funds reported $182M of Allergan Inc stock for Q1 2015, down 100% quarter-over-quarter.
- 0 funds opened new Allergan Inc positions in Q1 2015 and 801 closed out, a net change of -801 holders.
- The largest Allergan Inc buyer in Q1 2015 was Everence Capital Management, an estimated $202K added.
- The largest Allergan Inc seller in Q1 2015 was Pershing Square Capital Management, an estimated $5.66B sold.
Based on aggregated 13F filings for Q1 2015.